Your Body Shape Is Changing, and Your Genes May Be Why.

Your FTO gene has a straightforward job: it produces a protein that helps regulate appetite satiety signals. When this system works normally, your brain registers fullness after eating and naturally stops signaling for more food. It’s the biological brakes on hunger.

The FTO A allele variant, carried by roughly 45% of people with European ancestry, disrupts this satiety signaling. People with this variant don’t feel full the way others do after identical meals. Their brains receive weaker “stop eating” signals, so they naturally consume more calories. They also tend to crave high-fat, calorie-dense foods more intensely than people without the variant.

This shows up as constant low-level hunger throughout the day. You eat lunch and feel satisfied for 20 minutes, then the hunger returns. You finish dinner and 90 minutes later you’re in the kitchen looking for something to eat. Standard “willpower” advice misses the point entirely. Your appetite regulation system is biologically different, not weaker.

Your MC4R gene produces a receptor in your brain’s appetite control center (the hypothalamus) that receives “I’m full” signals from your body. This receptor is critical for translating hunger hormones into the feeling of fullness. It’s one of the most powerful appetite regulators your brain has.

Variants in MC4R impair this receptor’s function, and the effect is substantial. Even small reductions in MC4R function create a strong predisposition toward weight gain and difficulty with satiety. People with certain MC4R variants feel less satisfied after eating and struggle with a higher internal appetite setpoint. Roughly 5% of people with severe obesity carry MC4R variants.

The experience is often described as feeling hungry even immediately after eating a full meal. Your body doesn’t register adequate fullness, so you keep eating past the point where others would naturally stop. Food feels less satisfying overall. Portion control feels exhausting because your brain’s satiety system is working against you.

Your PPARG gene controls a master switch that tells your body how to handle dietary fat. It regulates peroxisome proliferator-activated receptor gamma, a nuclear receptor that determines whether incoming calories are stored as body fat or partitioned elsewhere. It’s essentially your fat storage thermostat.

The Pro12 allele of PPARG, found in roughly 25% of the population, promotes more efficient fat storage. People carrying this variant convert dietary calories into body fat more readily than others, even on identical diets. They also respond poorly to low-fat diets because their fat storage machinery is optimized to hang onto fat. Their bodies resist the calorie deficit that would work for someone with different PPARG genetics.

What this means in practice: you cut fat from your diet hoping to lose weight, and it barely works. Or you cut calories across the board and lose muscle before fat. Your body prefers to store fat and resists releasing it. Weight loss happens, but it comes slowly and unevenly. Body composition doesn’t shift the way fitness advice suggests it should.

Your ADRB2 gene produces a receptor on the surface of fat cells that receives the signal to release stored fat during exercise. When you work out, your body releases adrenaline and noradrenaline (catecholamines), and these hormones bind to ADRB2 receptors, telling fat cells to release stored energy. It’s how exercise is supposed to mobilize your fat stores.

Common variants in ADRB2 (Gln27Glu and Arg16Gly), carried by roughly 40% of the population, reduce the efficiency of this fat-release signal. People with these variants have fat cells that respond weakly to exercise-induced adrenaline, releasing significantly less stored fat during the same workout as someone without the variant. They’re working just as hard, sweating just as much, but mobilizing less fat for fuel.

This appears as frustration during exercise. You do cardio consistently and see minimal changes in body composition. You burn calories but don’t seem to burn fat. Other people drop weight quickly with exercise; you don’t see the same results despite similar effort. Your fat cells are resistant to the mobilization signal that should be triggering fat loss.

Your LEPR gene produces the leptin receptor, which sits on cells in your hypothalamus and receives the signal from the satiety hormone leptin. Leptin is released by fat cells in proportion to your body fat stores, and it tells your brain how much energy you have available. The leptin receptor is how your brain interprets this signal. Without functional leptin signaling, your brain doesn’t know how much fat you’re carrying.

LEPR variants, found in roughly 20-30% of the population, impair leptin signaling. When leptin receptor function is reduced, your brain doesn’t receive adequate satiety signals, even though leptin is being produced normally. It’s a communication breakdown. Your body is releasing the satiety hormone, but your brain isn’t receiving the message clearly.

The lived experience is chronic low-level hunger that doesn’t resolve with adequate food intake. You eat enough calories, you eat adequate protein, but your brain still perceives energy scarcity. You feel driven to eat more than your body actually needs. Dieting feels especially torturous because you’re fighting a neurological signal telling you that you’re starving, even though you’re not.

Your ACTN3 gene produces alpha-actinin-3, a protein that stabilizes the contractile machinery in fast-twitch muscle fibers. Fast-twitch fibers are responsible for explosive power, sprinting, and the intensity that burns the most calories per unit of effort. If you have functional ACTN3, your fast-twitch fibers are optimized for power.

The X/X null variant of ACTN3, found in roughly 18% of people with European ancestry, produces a non-functional version of the protein. People with the X/X genotype lack functional alpha-actinin-3 in their fast-twitch fibers, which reduces their explosive power capacity but often gives them a natural endurance advantage. Their muscle fiber profile is biologically optimized for sustained effort rather than short bursts.

Body composition-wise, this translates to a different training response. High-intensity interval training and heavy strength work produce explosive power but may not reshape your body the way they do for people with intact ACTN3. You may feel more naturally drawn to steady-state cardio or long-duration activities, yet see body composition changes from these activities that others would consider slow. Your body responds differently to different training intensities.